Management of Severe Respiratory Distress in COPD with Aspiration Risk

Immediate Oxygen Management

The European Respiratory Society recommends starting with controlled low-flow oxygen immediately to address critical hypoxemia, targeting oxygen saturation of 88-92% 1, 2
The British Thoracic Society suggests beginning with 24% Venturi mask at 2-3 L/min or 28% Venturi mask at 4 L/min, targeting oxygen saturation of 88-92% 3
The European Respiratory Society states that prevention of tissue hypoxia supersedes CO2 retention concerns, and if saturation remains below 88%, oxygen delivery should be escalated 1, 2
Arterial blood gas should be obtained within 30-60 minutes of starting oxygen to assess for hypercapnia and acidosis, as recommended by the British Thoracic Society 3, 4

The European Respiratory Society recommends assessing for non-invasive ventilation (NIV) versus intubation based on blood gas results, and initiating NIV immediately if pH <7.35 with elevated PaCO2 after 30 minutes of optimal medical therapy 3
The British Thoracic Society suggests managing patients in ICU/HDU with NIV readiness for intubation if pH <7.25 (H+ >56 nmol/L) 1, 5
The European Respiratory Society recommends proceeding to intubation if respiratory acidosis worsens after 1-2 hours of NIV on optimal settings 5

The European Respiratory Society recommends administering nebulized bronchodilators immediately upon arrival, using a short-acting β-agonist (albuterol/salbutamol) plus ipratropium via nebulizer every 2-4 hours 1, 2
Nebulization is preferred over MDI given severe distress and inability to coordinate, as stated by the European Respiratory Society 1

The European Respiratory Society recommends starting corticosteroids immediately for acute exacerbation, using prednisone 30-40 mg orally daily for 10-14 days if patient can tolerate oral intake 1, 2
If unable to take oral, the European Respiratory Society suggests giving an equivalent IV dose for up to 14 days 1, 2

The European Respiratory Society recommends initiating antibiotics immediately for ICU-level severity with aspiration risk, using first-line amoxicillin/clavulanate or alternative respiratory fluoroquinolone (levofloxacin, moxifloxacin) 1, 2
Anaerobic coverage is essential, and amoxicillin/clavulanate is superior to fluoroquinolones alone for this indication, as stated by the European Respiratory Society 1

The British Thoracic Society recommends positioning the patient upright to reduce aspiration risk, and suctioning the airway if accessible secretions are compromising ventilation 3
Early intubation should be considered if unable to protect the airway given aspiration history and current secretion burden, as suggested by the British Thoracic Society 5

The British Thoracic Society recommends intensive monitoring, including arterial blood gases at baseline, 30-60 minutes after oxygen initiation, and with any clinical deterioration 3, 4
Continuous pulse oximetry should be used, targeting 88-92% oxygen saturation, as recommended by the British Thoracic Society 3
The European Respiratory Society suggests monitoring for worsening acidosis (pH <7.25) or rising PaCO2 indicating need for ventilatory support 1, 2

The European Respiratory Society recommends ICU/HDU admission for severe respiratory distress with aspiration risk, requiring ICU-level monitoring and facilities for immediate intubation 1, 2
The British Thoracic Society suggests that facilities for immediate intubation must be available given high risk of NIV failure 5